Advertisement
Mr. Thomas Bailey, Angiotech's Chief Financial Officer, is scheduled topresent on Wednesday, March 26, beginning at approximately 8:00 am MountainTime. A question and answer session will immediately follow the presentation.
Advertisement
Presentations at this conference will not be webcast. More information isavailable on the Angiotech website (www.angiotech.com) under the Investorssection.
About Angiotech
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical andmedical device company with over 1,500 dedicated employees. Angiotechdiscovers, develops and markets innovative treatment solutions for diseases orcomplications associated with medical device implants, surgical interventionsand acute injury. To find out more about Angiotech (NASDAQ: ANPI, TSX: ANP),please visit our website at www.angiotech.com.
CONTACT: Deirdre Neary, Manager, Investor Relations, AngiotechPharmaceuticals, Inc., (604) 222-7056, [email protected]
SOURCE Angiotech Pharmaceuticals, Inc.